Assenagon Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,324
Closed -$714K 1487
2024
Q1
$714K Sell
24,324
-9
-0% -$287 ﹤0.01% 1129
2023
Q4
$885K Hold
24,333
﹤0.01% 1128
2023
Q3
$781K Sell
24,333
-25
-0.1% -$849 ﹤0.01% 1106
2023
Q2
$763K Hold
24,358
﹤0.01% 1034
2023
Q1
$555K Hold
24,358
﹤0.01% 1199
2022
Q4
$831K Hold
24,358
﹤0.01% 1082
2022
Q3
$740K Sell
24,358
-8
-0% -$274 ﹤0.01% 1005
2022
Q2
$907K Hold
24,366
﹤0.01% 1104
2022
Q1
$1.1M Sell
24,366
-20,871
-46% -$913K ﹤0.01% 1028
2021
Q4
$2.18M Sell
45,237
-58,349
-56% -$2.94M 0.01% 787
2021
Q3
$5.76M Sell
103,586
-2,230
-2% -$124K 0.02% 392
2021
Q2
$5.74M Buy
105,816
+19,719
+23% +$1.08M 0.02% 454
2021
Q1
$4.83M Buy
86,097
+1,622
+2% +$80.9K 0.02% 517
2020
Q4
$3.68M Buy
84,475
+10,875
+15% +$428K 0.02% 413
2020
Q3
$2.86M Sell
73,600
-31,200
-30% -$1.37M 0.02% 494
2020
Q2
$4.53M Buy
104,800
+88,486
+542% +$3.35M 0.03% 348
2020
Q1
$544K Buy
+16,314
New +$589K ﹤0.01% 627
2019
Q4
Sell
-44,629
Closed -$2.04M 926
2019
Q3
$2.04M Sell
44,629
-66,148
-60% -$2.88M 0.01% 400
2019
Q2
$4.78M Buy
+110,777
New +$4.68M 0.04% 302
2019
Q1
Sell
-18,248
Closed -$862K 1106
2018
Q4
$862K Sell
18,248
-19,857
-52% -$1.19M 0.01% 693
2018
Q3
$2.85M Buy
+38,105
New +$2.62M 0.03% 433

Other funds holding SRDX

Assenagon Asset Management's SRDX Position: Q2 2024 in Review

Assenagon Asset Management sold out of Surmodics (SRDX) in Q2 2024, closing a stake of 24,324 shares — an estimated $714K sold.

Assenagon Asset Management first reported a position in SRDX in Q3 2018 and held it in 21 quarters. The position peaked at $5.76M in Q3 2021. 124 funds tracked by Wall St. Rank hold SRDX as of Q2 2024.

  • Assenagon Asset Management reported no remaining Surmodics position as of Q2 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 24,324 Surmodics shares in Q2 2024, an estimated $714K.
  • Assenagon Asset Management first reported a position in Surmodics in Q3 2018 and held it in 21 quarters.
  • Assenagon Asset Management's Surmodics position peaked at $5.76M in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Surmodics as of Q2 2024.

Based on Assenagon Asset Management's 13F filing for Q2 2024, filed 18 Jul 2024.